SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-227940
Filing Date
2024-09-27
Accepted
2024-09-27 16:02:00
Documents
14
Period of Report
2024-09-26
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d310466d8k.htm   iXBRL 8-K 29018
2 EX-99.1 d310466dex991.htm EX-99.1 14726
  Complete submission text file 0001193125-24-227940.txt   176224

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bmea-20240926.xsd EX-101.SCH 2866
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bmea-20240926_lab.xml EX-101.LAB 18738
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bmea-20240926_pre.xml EX-101.PRE 11718
16 EXTRACTED XBRL INSTANCE DOCUMENT d310466d8k_htm.xml XML 3758
Mailing Address 900 MIDDLEFIELD ROAD 4TH FLOOR REDWOOD CITY CA 94063
Business Address 900 MIDDLEFIELD ROAD 4TH FLOOR REDWOOD CITY CA 94063 (650) 980-9099
Biomea Fusion, Inc. (Filer) CIK: 0001840439 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40335 | Film No.: 241334808
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)